A comprehensive view of Cedars-Sinai. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Cedars-Sinai Behavioral Health App launches on Apple Vision Pro; app expands access to mental health support for patients, offering self-administered, AI-enabled therapy
Published:
February 02, 2024
by Cedars-Sinai
|
Cedars-Sinai President and CEO Thomas M. Priselac to retire; Priselac will continue to lead Cedars-Sinai until board of directors has completed the search for a successor
Published:
January 31, 2024
by Cedars-Sinai
|
Older adults using five or more medications have higher risk association with falls, fractures, hospitalization, cognitive decline, Cedars-Sinai study finds; researchers note lack of a clear set of practices to help patients on multiple drugs
Published:
January 29, 2024
by Cedars-Sinai
|
Cedars-Sinai study finds behavioral activation therapy equally effective as antidepressant medications for treating depression in heart failure patients; therapy offers similar results, reducing severity of depressive symptoms by over 50%
Published:
January 19, 2024
by Cedars-Sinai
|
Study finds Hispanic and Latino individuals with chronic kidney disease have significant risk for sudden cardiac arrest reports Smidt Heart Institute at Cedars-Sinai; disease screening and prevention are vital due to the condition's low survival rate
Published:
October 11, 2023
by Cedars-Sinai
|
Ask us about our R&D/Patents market view